HKD 0.05
(4.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 14.88 Million CNY | 174.71% |
2022 | -19.92 Million CNY | -53.6% |
2021 | -12.96 Million CNY | -191.63% |
2020 | -4.44 Million CNY | 66.84% |
2019 | -13.41 Million CNY | -957.65% |
2018 | -1.26 Million CNY | -122.16% |
2017 | 5.72 Million CNY | -65.83% |
2016 | 16.74 Million CNY | 133.06% |
2015 | -50.65 Million CNY | 29.77% |
2014 | -72.12 Million CNY | -152.96% |
2013 | 136.18 Million CNY | -74.57% |
2012 | 535.54 Million CNY | 187.04% |
2011 | -615.26 Million CNY | -567.62% |
2010 | 131.57 Million CNY | -70.91% |
2009 | 452.25 Million CNY | 32.27% |
2008 | 341.92 Million CNY | 87.4% |
2007 | 182.45 Million CNY | 53.89% |
2006 | 118.55 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 1.71 Million CNY | 0.0% |
2023 Q2 | 4.6 Million CNY | 0.0% |
2023 FY | 14.88 Million CNY | 174.71% |
2023 Q4 | 9.64 Million CNY | 0.0% |
2022 Q2 | -15.21 Million CNY | 0.0% |
2022 FY | -19.92 Million CNY | -53.6% |
2022 Q4 | -4.71 Million CNY | 0.0% |
2021 FY | -12.96 Million CNY | -191.63% |
2021 Q2 | -14.73 Million CNY | 0.0% |
2021 Q4 | 1.76 Million CNY | 0.0% |
2020 Q4 | 732 Thousand CNY | 0.0% |
2020 Q2 | -5.17 Million CNY | 0.0% |
2020 FY | -4.44 Million CNY | 66.84% |
2019 FY | -13.41 Million CNY | -957.65% |
2019 Q4 | 4.62 Million CNY | 0.0% |
2019 Q2 | -18.03 Million CNY | 0.0% |
2018 Q2 | -11.41 Million CNY | 0.0% |
2018 FY | -1.26 Million CNY | -122.16% |
2018 Q4 | 10.14 Million CNY | 0.0% |
2017 Q2 | -7.25 Million CNY | 0.0% |
2017 FY | 5.72 Million CNY | -65.83% |
2017 Q4 | 12.97 Million CNY | 0.0% |
2016 FY | 16.74 Million CNY | 133.06% |
2016 Q4 | -2.18 Million CNY | 0.0% |
2016 Q2 | 18.92 Million CNY | 0.0% |
2015 FY | -50.65 Million CNY | 29.77% |
2015 Q2 | -34.73 Million CNY | 0.0% |
2014 FY | -72.12 Million CNY | -152.96% |
2014 Q4 | -26.88 Million CNY | 0.0% |
2014 Q2 | -45.23 Million CNY | 0.0% |
2013 FY | 136.18 Million CNY | -74.57% |
2013 Q3 | -35.7 Million CNY | 57.7% |
2013 Q4 | -28.65 Million CNY | 19.73% |
2013 Q2 | -84.39 Million CNY | -136.4% |
2013 Q1 | -35.7 Million CNY | 0.0% |
2012 Q4 | -35.7 Million CNY | 73.27% |
2012 Q2 | -133.55 Million CNY | 0.0% |
2012 Q1 | -133.55 Million CNY | 0.0% |
2012 FY | 535.54 Million CNY | 187.04% |
2012 Q3 | -133.55 Million CNY | 0.0% |
2011 Q1 | -153.6 Million CNY | 0.0% |
2011 FY | -615.26 Million CNY | -567.62% |
2011 Q2 | -153.6 Million CNY | 0.0% |
2011 Q3 | -153.6 Million CNY | 0.0% |
2011 Q4 | -133.55 Million CNY | 13.05% |
2010 FY | 131.57 Million CNY | -70.91% |
2010 Q3 | -29.63 Million CNY | 0.0% |
2010 Q2 | -29.63 Million CNY | 0.0% |
2010 Q1 | -29.63 Million CNY | 0.0% |
2010 Q4 | -153.6 Million CNY | -418.37% |
2009 FY | 452.25 Million CNY | 32.27% |
2009 Q3 | 113.64 Million CNY | 0.0% |
2009 Q2 | 113.64 Million CNY | 0.0% |
2009 Q1 | 113.64 Million CNY | 0.0% |
2009 Q4 | -29.63 Million CNY | -126.07% |
2008 Q1 | 86.26 Million CNY | 0.0% |
2008 FY | 341.92 Million CNY | 87.4% |
2008 Q2 | 86.26 Million CNY | 0.0% |
2008 Q3 | 86.26 Million CNY | 0.0% |
2008 Q4 | 113.64 Million CNY | 31.74% |
2007 Q4 | 86.26 Million CNY | 87.61% |
2007 FY | 182.45 Million CNY | 53.89% |
2007 Q3 | 45.97 Million CNY | 0.0% |
2007 Q2 | 45.97 Million CNY | 0.0% |
2007 Q1 | 45.97 Million CNY | 0.0% |
2006 Q4 | 45.97 Million CNY | 54.43% |
2006 Q2 | 29.77 Million CNY | 0.0% |
2006 Q1 | 29.77 Million CNY | 0.0% |
2006 FY | 118.55 Million CNY | 0.0% |
2006 Q3 | 29.77 Million CNY | 0.0% |
2005 Q4 | 29.77 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | -3.73 Million HKD | 498.127% |
Innovative Pharmaceutical Biotech Limited | -13.43 Million HKD | 210.779% |
China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | 664.568% |
Prosperous Future Holdings Limited | -30.27 Million HKD | 149.161% |
Huasheng International Holding Limited | 994 Thousand HKD | -1397.183% |
Fourace Industries Group Holdings Limited | 39.7 Million HKD | 62.522% |
Evergreen Products Group Limited | 81.06 Million HKD | 81.641% |
EC Healthcare | 186.03 Million HKD | 92.0% |
Ming Fai International Holdings Limited | 144.06 Million HKD | 89.67% |
Blue Moon Group Holdings Limited | 130.43 Million HKD | 88.59% |
SuperRobotics Holdings Limited | -7.88 Million HKD | 288.858% |
Takbo Group Holdings Limited | 9.68 Million HKD | -53.629% |
Hyfusin Group Holdings Limited | 138.63 Million HKD | 89.265% |